Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Agents that increase cellular cyclic AMP inhibit proliferative activity and decrease lipid content in cells cultured

V V Tertov, A N Orekhov, V N Smirnov

    Artery
    |January 1, 1986
    PubMed
    Summary

    Cholera toxin and related compounds reduce cell proliferation and lipid accumulation in human atherosclerotic intimal cells. These findings suggest potential therapeutic targets for atherosclerosis by modulating cellular processes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Proinflammatory Activation of Monocytes in Patients with Immunoinflammatory Rheumatic Diseases.

    Doklady. Biochemistry and biophysics·2024
    Same author

    Sialic acid as the potential link between lipid metabolism and inflammation in the pathogenesis of atherosclerosis.

    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2023
    Same author

    Animal models of human atherosclerosis: current progress.

    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2020
    Same author

    Correction to: Rehmanniae Radix Preparata suppresses bone loss and increases bone strength through interfering with canonical Wnt/β-catenin signaling pathway in OVX rats.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
    Same author

    An update on the tools for creating transgenic animal models of human diseases - focus on atherosclerosis.

    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2019
    Same author

    [Dietary phospholipids: lipid metabolism and risk factors for cardiovascular diseases].

    Voprosy pitaniia·2019

    Area of Science:

    • Biochemistry
    • Cell Biology
    • Cardiovascular Research

    Background:

    • Atherosclerosis is a chronic inflammatory disease characterized by lipid deposition and intimal cell proliferation.
    • Understanding cellular mechanisms in atherosclerotic lesions is crucial for developing targeted therapies.

    Purpose of the Study:

    • To investigate the effects of specific signaling molecules on intimal cells from human atherosclerotic aortas.
    • To determine the impact of these agents on cellular proliferation and lipid metabolism.

    Main Methods:

    • Primary cell cultures of intimal cells isolated from human atherosclerotic aorta.
    • Measurement of 3H-thymidine uptake to assess DNA synthesis and cell proliferation.
    • Quantification of cholesteryl ester, triglyceride, phospholipid, and free cholesterol content.

    Related Experiment Videos

    Main Results:

    • Cholera toxin, methylisobutylxanthine, prostacyclin (PGI2) analogues, and dibutyryl cyclic AMP significantly inhibited 3H-thymidine uptake (2-7 fold) in intimal cells.
    • These agents also led to a decrease in cholesteryl ester and triglyceride levels within the cells.
    • No significant changes were observed in the cellular content of phospholipids and free cholesterol.

    Conclusions:

    • Modulators of cyclic AMP signaling pathways can inhibit proliferation and alter lipid profiles in human atherosclerotic intimal cells.
    • These findings highlight the role of cyclic AMP in regulating cellular behavior within atherosclerotic lesions.
    • Targeting these pathways may offer a novel therapeutic strategy for managing atherosclerosis.